Clinical trials
Recruiting Liposarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2024 | 8 |
| 2025 | 10 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Baylor College of Medicine | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Oslo University Hospital | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Australia and New Zealand Sarcoma Association | 1 |
| Epkin | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fudan University | 1 |
| Grupo Espanol de Investigacion en Sarcomas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liposarcoma | 27 |
| Sarcoma | 14 |
| Leiomyosarcoma | 12 |
| Histiocytoma, Malignant Fibrous | 7 |
| Dermatofibrosarcoma | 5 |
| Sarcoma, Synovial | 5 |
| Fibrosarcoma | 4 |
| Hemangiosarcoma | 4 |
| Rhabdomyosarcoma | 4 |
| Endodermal Sinus Tumor | 3 |
Trials
Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.